92 related articles for article (PubMed ID: 22217516)
21. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-β1 stimulates mesenchymal stem cell proliferation by altering cell cycle through FAK-Akt-mTOR pathway.
Sun J; Zhou Y; Ye Z; Tan WS
Connect Tissue Res; 2019 Jul; 60(4):406-417. PubMed ID: 30642198
[No Abstract] [Full Text] [Related]
23. Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas.
Sebestyén A; Márk Á; Hajdu M; Nagy N; Molnár A; Végső G; Barna G; Kopper L
Cytokine; 2015 Jun; 73(2):219-24. PubMed ID: 25794661
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.
Lee SJ; Yang EK; Kim SG
Mol Pharmacol; 2006 Jul; 70(1):415-25. PubMed ID: 16611854
[TBL] [Abstract][Full Text] [Related]
25. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
Liu NN; Zhao N; Cai N
IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
[TBL] [Abstract][Full Text] [Related]
26. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758
[TBL] [Abstract][Full Text] [Related]
27. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
[TBL] [Abstract][Full Text] [Related]
28. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-beta1 enhanced vascular endothelial growth factor synthesis in mesenchymal stem cells.
Wang XJ; Dong Z; Zhong XH; Shi RZ; Huang SH; Lou Y; Li QP
Biochem Biophys Res Commun; 2008 Jan; 365(3):548-54. PubMed ID: 18023419
[TBL] [Abstract][Full Text] [Related]
30. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
[TBL] [Abstract][Full Text] [Related]
31. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway.
Lamouille S; Derynck R
J Cell Biol; 2007 Jul; 178(3):437-51. PubMed ID: 17646396
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
[TBL] [Abstract][Full Text] [Related]
33. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
[TBL] [Abstract][Full Text] [Related]
34. Identification of two novel inhibitors of mTOR signaling pathway based on high content screening.
Yan J; Zhou H; Kong L; Zhang J; Zhao Q; Li Y
Cancer Chemother Pharmacol; 2013 Oct; 72(4):799-808. PubMed ID: 23934262
[TBL] [Abstract][Full Text] [Related]
35. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
[TBL] [Abstract][Full Text] [Related]
36. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.
Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR
Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051
[TBL] [Abstract][Full Text] [Related]
37. Metformin inhibits proliferation and proinflammatory cytokines of human keratinocytes in vitro via mTOR-signaling pathway.
Liu Y; Yang F; Ma W; Sun Q
Pharm Biol; 2016 Jul; 54(7):1173-8. PubMed ID: 26305116
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor (TGF)-beta1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation in vitro: peroxisome proliferator-activated receptor gamma acts as a negative regulator of TGF-beta1.
Chang HJ; Lee JH; Hwang KJ; Kim MR; Chang KH; Park DW; Min CK
Fertil Steril; 2008 Oct; 90(4 Suppl):1357-65. PubMed ID: 18082740
[TBL] [Abstract][Full Text] [Related]
39. Involvement of KLF14 and egr-1 in the TGF-beta1 action on Leydig cell proliferation.
Gonzalez CR; Vallcaneras SS; Calandra RS; Gonzalez Calvar SI
Cytokine; 2013 Feb; 61(2):670-5. PubMed ID: 23317878
[TBL] [Abstract][Full Text] [Related]
40. The Drosophila protein kinase LK6 is regulated by ERK and phosphorylates the eukaryotic initiation factor eIF4E in vivo.
Parra-Palau JL; Scheper GC; Harper DE; Proud CG
Biochem J; 2005 Feb; 385(Pt 3):695-702. PubMed ID: 15487973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
